Stockholm - Delayed Quote SEK

Ascelia Pharma AB (publ) (ACE.ST)

3.8550
+0.0600
+(1.58%)
At close: May 9 at 5:29:33 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
--
--
--
3,892
8,723
Gross Profit
0
0
0
0
0
Operating Expense
67,765
67,765
110,914
147,670
137,897
Operating Income
-67,765
-67,765
-110,914
-147,670
-137,897
Net Non Operating Interest Income Expense
-12,358
-12,358
1,307
587
-67
Pretax Income
-80,124
-80,124
-109,607
-133,155
-129,523
Tax Provision
-94
-94
-319
-1,933
-3,620
Net Income Common Stockholders
-80,029
-80,029
-109,288
-131,223
-125,903
Diluted NI Available to Com Stockholders
-80,029
-80,029
-109,288
-131,223
-125,903
Basic EPS
-1.48
--
-3.24
-2.61
-2.64
Diluted EPS
-1.48
--
-3.24
-2.61
-2.64
Basic Average Shares
54,001.1870
--
33,719.7790
50,302.0350
47,643.1490
Diluted Average Shares
54,001.1870
--
33,719.7790
50,302.0350
47,643.1490
Total Operating Income as Reported
-67,766
-67,766
-110,914
-147,007
-137,948
Total Expenses
67,765
67,765
110,914
147,670
137,897
Net Income from Continuing & Discontinued Operation
-80,029
-80,029
-109,288
-131,223
-125,903
Normalized Income
-80,029
-80,029
-109,288
-131,223
-125,903
Interest Income
1,584
1,584
3,725
635
10
Interest Expense
13,942
13,942
2,418
48
77
Net Interest Income
-12,358
-12,358
1,307
587
-67
EBIT
-66,182
-66,182
-107,189
-133,107
-129,446
EBITDA
-66,182
-66,182
-107,189
-133,107
-129,446
Reconciled Cost of Revenue
--
--
--
3,892
8,723
Net Income from Continuing Operation Net Minority Interest
-80,029
-80,029
-109,288
-131,223
-125,903
Total Unusual Items Excluding Goodwill
--
--
0
0
0
Total Unusual Items
--
--
0
0
0
Normalized EBITDA
-66,182
-66,182
-107,189
-133,107
-129,446
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/13/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ELIC.ST Elicera Therapeutics AB (publ)
5.12
+16.36%
 
XSPRAY.ST Xspray Pharma AB (publ)
32.10
-8.29%
 
XBRANE.ST Xbrane Biopharma AB (publ)
0.2032
-1.26%
 
ONCO.ST Oncopeptides AB (publ)
1.8240
-2.88%
 
BINV.ST BioInvent International AB (publ)
32.60
-1.21%
 
ATORX.ST Alligator Bioscience AB (publ)
4.1500
+4.56%
 
HNSA.ST Hansa Biopharma AB (publ)
25.94
+1.33%
 
IMMU.ST Mendus AB (publ)
5.78
-3.51%
 
ACTI.ST Active Biotech AB (publ)
0.0908
-0.66%
 
CANTA.ST Cantargia AB (publ)
1.6300
+5.16%